Diodes Incorporated

Phase A — Understand the business

Lens 1 · Company Overview

Business model. Diodes designs, manufactures and sells high-volume, application-specific standard semiconductors into five end markets. It runs a hybrid manufacturing model — its own wafer fabs (Shanghai & Wuxi China; Oldham England; Greenock Scotland; Hsinchu Taiwan; South Portland Maine) plus assembly/test (China, Taiwan, Germany), and externally sourced capacity — so it can flex output with the cycle. The differentiation is not leading-edge nodes; it is packaging expertise, breadth, cost, and design-in service ("total systems solutions"). It explicitly reports as a single segment ("standard semiconductor products") — there is no internal product-line P&L disclosed.

Customers / channel. >50,000 customers; for FY2025 direct + EMS customers were 35% of net sales (so distribution ≈ 65%). Distributor sales $959.7M vs direct $522.4M in FY2025. This distribution-heavy mix is why revenue recognition carries large reserve estimates (ship-and-debit, stock-rotation, price-protection — see Lens 10).

Contract structure (the key risk term). "Generally, our customers may cancel orders on short notice without incurring a penalty" and backlog "is not an accurate measure of our future sales". This is the opposite of take-or-pay — Diodes has no contractual demand floor; it lives and dies on the book-and-ship cycle. That is precisely what made FY2024 (-21% revenue) so brutal and FY2026 so violent on the way up.

End-market mix (FY2025 / FY2024 / FY2023):

The secular shift to watch: Computing has climbed from 23%→27% of revenue, driven by AI-server / data-center content (high-power transient protection, supervisory reset ICs, low-RDS(on) switches, PCIe mux buffers). Industrial fell from 27%→23% across the downcycle. Automotive has held flat at 19% but is a stated margin-accretive priority.

Lens 2 · Supply Chain

Map upstream → Diodes → end customer, named:

• Upstream inputs: silicon wafers, aluminium/copper lead frames, gold & copper wire, molding compounds, chemicals/gases. No minimum/continuing supply obligations with suppliers — flexible but exposed to lead-time/price shocks. Gold is called out as a 2025 cost pressure that raised average unit cost.
• Related-party wafer/material suppliers (named): Nuvoton Technology — Diodes buys wafers (FY2025 purchases $6.5M; a ~$1.4M wafer purchase agreement running into Q2-2026); board member Warren Chen also sits on Nuvoton's board. JCP (Jiyuan Crystal Photoelectric) — frequency-control material, equity-method investee. Atlas Magnetics — early-stage fabless wafer-design VIE, majority-owned, purchases scaling fast ($0.2M→$4.5M→$10.3M FY23→24→25). Keylink — 5% JV partner in the Shanghai A&T plants; Diodes leases the Shanghai facilities from Keylink, subcontracts metal-plating/environmental, and pays a consulting fee (plating/rental/consulting expense $13.9M in 2025).
• Own manufacturing (the chokepoint concentration): the value-add is in-house wafer fab + proprietary packaging/test. Geographic chokepoint: ~77–78% of revenue and the bulk of manufacturing sit in Asia (China + Taiwan); the South Portland (Maine, ex-onsemi, 2022) and Greenock (Scotland, ex-TI, 2019) 200mm fabs are the Western diversification.
• Distribution → end customer: majority of units flow through global distributors and EMS providers into OEM end-products. End buyers are diffuse (automotive Tier-1s, industrial OEMs, AI-server/data-center builders, smartphone/consumer).

Single-source / chokepoint flags: (1) Asia manufacturing concentration is the dominant supply-chain risk — a Taiwan-Strait or China-tariff event hits both cost base and demand. (2) Acquired Western fabs (SPFAB/GFAB) are the deliberate hedge. (3) Gold/precious-metal input inflation is a live margin drag.

Lens 3 · Competitive Advantages (moats)

Honest read: Diodes' moat is narrow — cost, breadth, and service, not technology or switching costs.

• Stated strengths: flexible/scalable low-cost (Asia) manufacturing; integrated packaging expertise (multi-chip arrays, miniature packages); broad customer base / diverse end-markets (less single-customer risk); customer-focused design-in; experienced management.
• Real durable advantages: (a) Vertical integration + Asia cost base lets it win price-sensitive, high-volume sockets the bigger analog names won't chase. (b) Packaging IP — genuinely differentiated miniaturized/multi-chip packages. (c) Design-in stickiness — once a part is qualified into an automotive or industrial board (a "lengthy and expensive qualification process"), it tends to stay for the product life; this is the closest thing to a switching-cost moat, strongest in automotive.
• Where the moat is thin: these are standard products in a "highly fragmented, highly competitive" market. The 10-K names larger rivals — Infineon, onsemi, NXP, Renesas, Texas Instruments, Vishay, Nexperia, Epson, Kyocera — "many of which have greater financial, marketing, R&D and manufacturing resources". Diodes is a price-taker under "continuous pressure … to reduce the price of our products" (its own risk language). Weighted-average sales price fell 1.7% in FY2025 and 6.9% YoY in Q1-2026 even as volume surged (+15% FY25, +31.1% Q1-26) — i.e. it is buying share with price/mix.
• Bargaining power: weak over customers (no-penalty cancellations, distribution-mediated, price pressure); moderate over suppliers (no long-term obligations, can dual-source). It needs its customers more than they need it — except in qualified automotive sockets.

Lens 4 · Segments

Hard constraint honored: Diodes reports a single operating segment — there is no product-line revenue/EBITDA/operating-income breakout to source. segments.csv is empty. So segmentation here is by end market and geography only, both ``:

By geography — Net sales ($000):

Asia = 78% of FY2025 revenue; the recovery is broad but Asia-led in absolute dollars, while Q1-2026's incremental growth was led by Europe (automotive + communications). Q1-2026 geographic mix per the call: Asia 77%, Europe 14%, North America 9%.

By end market — trend & cause: Computing accelerating (23%→27%, AI-server content the driver). Industrial decelerated through the downturn (27%→23%) but is now re-accelerating with AI-infrastructure-linked industrial demand. Automotive flat share (19%) but growing in absolute dollars and prioritized for margin. Q1-2026 mix nudged Industrial→24%, Automotive→20%, Computing→26% — automotive + industrial = 44% of product revenue and the explicit margin engine.

Profitability by segment: not disclosed — n/a, single-segment reporter. What IS disclosable is the consolidated margin trajectory (Lens 5), which is the real story.

---

Phase B — Measure performance

Lens 5 · Earnings Result

The two-part story: revenue inflecting hard up; margins still a fraction of prior-peak.

Annual P&L ($000):

The FY2025 headline (+13% revenue, +50% EPS) flatters the operating reality. Operating income actually FELL 30% in FY2025 to a 2.4% margin (from 3.9%) — gross margin compressed 200bp (mix to lower-margin computing, gold cost, slower industrial) and opex grew faster than gross profit (R&D +$28.1M, +21%). The EPS gain was manufactured below the operating line: total other income jumped to $48.5M (from $12.2M) on (a) a +$28.6M unrealized investment gain — chiefly a +$33.3M mark-up of the Atlas equity stake — and (b) a +$13.7M gain on disposal of a subsidiary (TF Semiconductor). Strip the non-operating items and FY2025 was a low-quality year operationally.

The pivot is in the latest print (Q1-2026):

Q1-2026 is the fifth consecutive quarter of double-digit YoY growth (+22.1% YoY, +3.5% "above-seasonal" sequential) and — critically — the margin recovery is now operating-driven, not gimmick-driven: operating income leapt to $19.8M (4.9% margin) with only $2.7M of below-the-line help. vs consensus: revenue $405.5M beat ~$402.9M; non-GAAP EPS $0.43 beat $0.35.

Guidance / tone change. Q2-2026 guide: revenue ~$435M (±3%) (≈+31% YoY), GAAP gross margin 32.8% (±1%), non-GAAP EPS $0.60 (±$0.10) — midpoint above the ~$0.54 sell-side. Management hardened its 3-year interim targets to $2.0B revenue / ~$700M gross profit (35%+) / >$4.00 non-GAAP EPS, en route to the long-term $2.5B / $1.0B GP / 40% GM model.

Balance-sheet flags (mostly green): cash + STI $404.3M vs total debt ~$55.4M → net cash ~$321M. Zero drawn on the $225M revolver. Inventory is the yellow flag: $492.8M at Q1-2026, up from $471.5M, ≈169 days of COGS — high, and building into the recovery, which cuts both ways (ready for demand vs. obsolescence risk if the cycle rolls). Receivables actually fell (good — not outrunning revenue). Market reaction: despite the beat-and-raise, the stock dipped ~2.3% after-hours — a classic "priced for perfection" tell.

Lens 6 · Earnings Calls (sentiment trend)

No transcripts on the shelf (transcripts/ empty) — this lens is ``.

• Tone arc Q4-2024 → Q4-2025 → Q1-2026: from "trough / inventory digestion / muted" to "recovery + momentum + content expansion." Q4-2025 missed EPS but management used it to set the 3-year targets. Q1-2026 is unambiguously upbeat: "solid demand recovery and momentum," "above-seasonal," "fifth consecutive quarter of double-digit growth," "highest percentage increase since Q4-2021".
• Recurring phrases now: "design wins / design-in momentum," "content expansion," "total systems solutions," "AI server," "automotive and industrial" (the margin-mix mantra), "$2.5B / $1.0B / 40%."
• What they stopped saying: the FY2024 language of "soft demand," "inventory correction," "utilization headwinds." The narrative has flipped from defense to offense.
• Sentiment read: genuinely improving and credible on the top line; the unspoken tension is margin — they talk revenue and design wins far more than near-term gross-margin cadence, because GM is recovering only slowly (31.1%→31.8% over the quarter) against a 40% aspiration that is years out.

Lens 7 · Comps

Peer multiples are `` with date; where a specific cell is unsourced it is marked n/a. DIOD's own multiples are the headline:

Reads:

1. The whole peer set is trading on trough-recovery earnings, so every TTM/forward P/E is optically nosebleed (ON went from 180x→43x as earnings recovered; VSH 63x; DIOD 65x TTM / 38x fwd). This is normal at a cyclical bottom — but it means the multiple gives you no margin of safety; you are paying for the recovery, not getting it for free.
2. On EV/Sales ~3.3x, DIOD is cheaper than onsemi's ~8.8x P/S — but that gap is deserved: onsemi has structurally higher gross margins (40s%) and a SiC/automotive franchise; Diodes' through-cycle GM is low-30s. A sub-peer EV/Sales on a sub-peer-margin business is not a bargain.
3. 0% dividend, low ROE — capital is returned via opportunistic buybacks ($33.8M FY2025), not yield. ROE is structurally low (~3–4%) because of the large net-cash balance and modest margins.

Lens 8 · Stock-Price Catalysts

Pattern of >5% moves (mostly / cumulative-return table):

• Five-year total return has been a round-trip then a moonshot. 10-K performance graph (cum. $ from $100 at 12/31/2020): 155.8 (2021) → 108.0 (2022) → 114.2 (2023) → 87.4 (2024) → 70.0 (2025) — i.e. shares fell 20% in 2025 and ~46% off the 2021 peak. Annual returns: +55.8% / -30.7% / +5.7% / -23.4% / -20.0%.
• Then 2026 inverted it: stock up ~50%+ YTD, all-time-high close $116.22 on 2026-06-03, now ~$122.74 (2026-06-22) — roughly a double off the late-2025 ~$45–53 level (the 10-K's own June-30-2025 reference price was $52.89; Nov–Dec 2025 buybacks executed at $45–50).
• What actually moves DIOD: (1) the semi cycle / book-to-bill — the dominant driver; the 2024 down-leg and 2026 up-leg explain the bulk of the move. (2) earnings beats + guidance raises — five straight double-digit-growth prints re-rated it. (3) AI-server narrative — the market is paying DIOD an "AI-content" multiple. (4) Competitor disruption — "Diodes seems to be benefiting from problems at Nexperia" (a share-gain tailwind that could reverse). (5) Recent product catalysts: automotive power-portfolio expansions drove single-day pops on 2026-06-18 and 2026-06-20.
• Lesson for the name: DIOD is a high-beta cyclical proxy — it overshoots both ways. The market reacts to the rate of change of demand, not the level of margin. Right now rate-of-change is maximally positive and fully appreciated.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO — Gary Yu (CEO since May 2025; President & Director since Jan 2024; prior COO). 16+ years at Diodes; before that ~10 yrs at Lite-On Semiconductor (VP WW Sales) and Texas Instruments (IT/finance/capacity planning). Insider-promoted operator, deep institutional knowledge, Asia-sales pedigree — well-matched to the design-in/content-expansion strategy. New-ish in the top seat, so the 3-year targets are his scorecard.
• CFO — Brett Whitmire (CFO since 2019, 8+ yrs at Diodes, 30 yrs in industry). Ex-Freescale (CFO, Analog & Sensors Division) and 20 years at TI (incl. 7 as VP, finance/ops for the Analog & Logic Division + corporate supply chain). Strong analog-finance credentials. Signed the effective-ICFR attestation with the CEO.
• Track record (quantified): the team grew revenue to a $1.66B FY2023 peak, navigated the -21% FY2024 trough, and is executing the snap-back. The blemish on the record is margin — peak operating margin was 15.1% (FY2023) and the model has never sustainably reached the 40% gross-margin goal that has been articulated for years.
• Capital allocation: (1) M&A-led growth — LSC (2020), GFAB/Scotland ex-TI (2019), SPFAB/Maine ex-onsemi (2022), Fortemedia (Oct 2024, voice/audio), ATX Malaysia JV 43% (2025, test/packaging). A serial, mostly-sensible bolt-on acquirer that buys capacity and adjacent tech. (2) Buybacks opportunistic — $100M authorization (May 2025), $33.8M used in FY2025 at $45–50, ~$66.2M remaining. Notably they bought back low (late 2025) — good timing. (3) No dividend, by policy — retains for reinvestment. (4) ROE/ROIC structurally low because of the cash pile + modest margins.
• Red flags (governance): the related-party web is the watch item, not a smoking gun — Keylink (5% JV partner; Diodes leases its Shanghai plants from Keylink and pays it ~$13.9M/yr plating/rental/consulting), Nuvoton (board interlock via Warren Chen), Atlas (majority-owned VIE that Diodes marked +$33.3M through FY2025 income — see Lens 10). These are long-disclosed, audited, and common for an Asia-integrated manufacturer, but they reduce reported-earnings quality and deserve monitoring.
• Archetype: professional-manager / insider-operator team, not founder-owners. Implication: competent, incremental, execution-focused; unlikely to bet the company, but also carrying a years-old margin promise that the market is now pricing as imminent.

Lens 10 · Forensic Red Flags

Forensic-analyst pass across IS / BS / CF. Overall: clean audit, effective ICFR, no enforcement history — but several earnings-quality and estimate-sensitivity items materially flatter the optics.

1. Low-quality FY2025 net income (the biggest flag). ~$48.5M of FY2025's $84.0M pre-tax income was non-operating: +$28.6M unrealized investment gains (mostly the +$33.3M Atlas mark-up), +$13.7M subsidiary-disposal gain, partly offset by a -$5.8M impairment. GAAP EPS of $1.43 overstates operating earnings power. The Q1-2026 print is cleaner (only $2.7M below-the-line), which is reassuring.
2. Atlas VIE treatment. Diodes holds a majority interest in Atlas Magnetics yet does NOT consolidate it — it argues it is a VIE for which Diodes "does not have the power to direct the activities that most significantly impact Atlas," hence not the primary beneficiary. The stake sits in Equity investments ($154.7M at Q1-2026) and is marked to fair value through the P&L (+$33.3M in 2025; +$2.5M Q1-2026; a -$1.2M impairment Q1-2026). Purchases from Atlas are also scaling ($10.3M in 2025). This is the single item most worth scrutiny — a majority-owned, marked-up, related-party investee whose gains drove reported EPS is exactly the kind of structure a short would probe. No allegation here; it is audited; but it is a genuine earnings-quality and complexity flag.
3. Ship-and-debit reserve — the Critical Audit Matter. Baker Tilly flagged it: a $255.6M reduction to FY2025 net sales for distributor incentives (ship-and-debit, stock-rotation, price-protection), estimated via look-back models. A 1% change moves net sales/AR by ~$1.0M. Distribution-heavy revenue is inherently estimate-laden; not a problem, but a sensitivity to watch each quarter.
4. Inventory building into the cycle. $492.8M / ~169 days at Q1-2026, rising. Stated as lower-of-cost-or-NRV, FIFO, with ongoing obsolescence review. The risk is asymmetric: a cycle roll-over would force write-downs straight through COGS.
5. SBC vs non-GAAP. Q1-2026 GAAP EPS $0.32 vs non-GAAP $0.43 — a ~34% non-GAAP uplift; FY2025 SBC was $25.7M. The non-GAAP/GAAP wedge (SBC + intangible amortization from the deal spree) is the number bulls quote and the multiple is built on. Watch that the gap doesn't widen.
6. FX noise. Recurring foreign-currency losses (-$12.8M FY2025) and a large AOCI swing; a UK defined-benefit plan underfunded ~$1.2M with a $33.4M AOCI net loss — immaterial to earnings but adds volatility.

Clean items (genuine positives): auditor Baker Tilly since 1993, unqualified opinion, ICFR effective, no restatement, fortress balance sheet (net cash ~$321M, ~0.03x net-debt/EBITDA on a net-cash basis), receivables not outrunning revenue.

Regulatory findings (required). Per regulatory/regulatory-findings.md (generated 2026-06-24 from SEC EDGAR EFTS): 0 SEC Litigation Releases and 0 AAERs naming Diodes Incorporated in the 2021–2026 window. Non-SEC web check ("Diodes Incorporated" + FTC/DOJ/FDA/consent-decree/settlement/penalty): no material enforcement actions surfaced. 10-K Item 3 (Legal Proceedings): boilerplate only — "from time to time … various legal proceedings that arise in the normal course of business … no current pending legal proceeding will [have] any material adverse effect" — no specific material litigation disclosed. Conclusion: No material regulatory or legal findings — verified via SEC EDGAR EFTS (LR, AAER), web search, and 10-K Item 3 as of 2026-06-24.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection

Bottom-up from actuals + guidance. Every input labeled; output ``. No forecast.ts create in the watchlist loop (per skill), but the base call is logged in prose below for later scoring. Fiscal year = calendar year.

Anchors: FY2025 actual rev $1,482M, GM 31.2%, GAAP EPS $1.43. Q1-2026 actual rev $405.5M, GAAP EPS $0.32 / non-GAAP $0.43. Q2-2026 guide rev ~$435M, GAAP GM 32.8%, non-GAAP EPS $0.60. Diluted share count ~46.1M and falling on buybacks.

FY2026 (base): H1 run-rate ≈ $405M + $435M = $840M; assume normal H2 seasonality with continued recovery → rev ~$1.73–1.78B (+17–20% YoY). GM drifting to ~32.5–33%. Non-GAAP EPS ~$2.30–2.55; GAAP EPS ~$1.80–2.05. (TTM non-GAAP EPS already ~$1.84 per.)

FY2027 / FY2028 paths:

• Bear: cycle peaks late-2026, revenue stalls ~$1.7B, GM stuck ~32%, opex grows → non-GAAP EPS ~$2.00–2.30 (flat-to-down). Plausible if the inventory build meets softening demand.
• Base: steady share-gain + content growth, revenue → ~$1.9B (FY27) toward the $2.0B interim target (FY28-ish), GM → 34–35%, operating leverage lifts EPS faster than revenue → non-GAAP EPS ~$2.90–3.40 (FY27) → ~$3.60–4.10 (FY28) — i.e. the >$4.00 target is a ~FY2028 outcome, not FY2026.
• Bull: AI-server/automotive content compounds, GM approaches the 35%+ interim and visibly tracks toward 40%, revenue >$2.0B early → non-GAAP EPS >$4.00 by FY2027.

Base-case forecast to track (would log via forecast.ts outside the loop): "DIOD FY2026 non-GAAP EPS ≥ $2.30, p≈0.65, resolves 2027-02-15." And the longer falsifier: "DIOD reaches ≥35% GAAP gross margin in any quarter on/before Q4-2027, p≈0.45." The 35%+/40% gross-margin milestone is the real thesis test — the stock at ~38x forward already embeds it.

Lens 12 · Bull vs Bear

Bull case. A genuine, broad-based cyclical recovery with a secular kicker: five straight quarters of double-digit growth, an above-seasonal Q1, a beat-and-raise, and a credible content story in AI-server + automotive + industrial (the high-margin 44% of revenue). The hybrid manufacturing model gives operating leverage on the way up — Q1 already showed op margin snapping from 0.4%→4.9%. Fortress balance sheet (net cash ~$321M, zero revolver draw) funds bolt-on M&A and buybacks. Management is hardening targets ($2.0B/$700M GP/>$4.00 EPS) and has the TI/analog pedigree to chase margin mix. If they execute toward even 35% gross margin, EPS power roughly doubles off FY2025 and the "expensive" multiple compresses into the growth. Plus a near-term share-gain tailwind from Nexperia's disruption.

Bear case (2–3 ways it permanently/structurally disappoints).

1. Valuation is the bear case. ~38x forward / ~65x TTM P/E, ~3.3x EV/Sales on a business whose through-cycle gross margin is low-30s and whose operating margin even at the FY2023 peak was 15%. The stock has doubled in 2026 and trades ABOVE the lead analyst PT ($120 Baird vs ~$122 spot) with a 67% "Strong Buy" consensus — the textbook setup for disappointment. The beat-and-raise was met with a -2.3% AH reaction: good news is in.
2. Margin may not get to the promise. The 40% gross-margin / $2.5B model has been articulated for years and never reached; mix to lower-margin computing and negative price (WASP -6.9% YoY in Q1) show Diodes is buying volume with price. If GM plateaus in the low-30s, the EPS-doubling thesis underpinning the multiple evaporates.
3. It's a price-taking cyclical with no demand floor. No-penalty cancellations, distribution-mediated, 77–78% Asia/China exposure, tariff/geopolitical risk, and a $493M / 169-day inventory build into the recovery. A cycle roll-over hits revenue, utilization, and inventory value simultaneously — the exact FY2024 playbook, which took the stock down ~46% from peak.

Pre-mortem (18 months out, thesis broke): the semi cycle peaked in mid/late-2026; book-to-bill rolled below 1.0; the inventory built in H1-2026 had to be written down; gross margin stalled at ~32% instead of marching to 35%; the AI-server "content" narrative proved lower-margin and more competitive than hoped; and a stock that had doubled on a recovery-and-margin story de-rated from ~38x to ~18x forward as estimates flattened — a 40%+ drawdown despite the business being fine. The killer wasn't a blow-up; it was paying a growth-and-margin multiple for a cyclical price-taker at the top of its rate-of-change.

Are multiples too high? Yes, on any normalized basis. They are defensible only if you underwrite the 35%+ gross-margin transition as near-certain and near-term. The market is doing exactly that.

Contrarian view (what the market refuses to see): the consensus is treating DIOD as an "AI-content compounder" and paying an AI multiple. It is actually a well-run, Asia-cost, price-taking, broad-line cyclical whose earnings quality in its last full year was propped by a related-party mark-up and a disposal gain, and whose flagship 40%-GM promise is years old and unmet. The recovery is real; the re-rating is the mistake.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case.

• What structurally breaks the model: Diodes earns its keep on high-volume standard parts where it is a declared price-taker ("continuous pressure to reduce price"). Its own data shows falling ASPs (-1.7% FY25, -6.9% Q1-26) offset by volume — a treadmill. Any demand air-pocket exposes the fixed-cost base (its own risk factor: "fixed costs combined with lower net sales … negative impact").
• Revenue concentration / what shifts: 77–78% Asia, distribution-mediated, no-penalty cancellations. A China-tariff escalation or a Taiwan-Strait event is a simultaneous demand-and-supply shock. The current Nexperia-disruption share gain is explicitly flagged as possibly turning into a headwind.
• Moat weaker than bulls think: competes against TI/onsemi/Infineon/NXP/Renesas/Vishay/Nexperia — all larger, all better-resourced. The "AI-server content" is real but is protection/power/interface glue, not scarce IP; it is contestable by exactly those better-capitalized peers.
• Most dangerous competitor bulls underestimate: onsemi and Infineon in automotive/industrial power, and the Chinese domestic discrete/analog vendors racing down the cost curve in Diodes' own backyard — the latter directly attack its one structural edge (Asia cost).
• Worst capital-allocation / accounting optics: the Atlas VIE (majority-owned, unconsolidated, +$33.3M P&L mark-up driving FY2025 EPS), the Keylink lease-and-fee web ($13.9M/yr to a 5% JV partner), the Nuvoton board interlock. None is illegal; together they lower earnings quality and are the thread a short pulls.
• What must hold for today's price: uninterrupted double-digit growth through 2026–27 and a gross-margin march from 31.8%→35%+ and no cycle roll and no China/tariff shock — simultaneously. That's a lot of "ands" at ~38x forward.
• If growth disappoints 20–30%: revenue back toward ~$1.4–1.5B, op margin re-compresses toward low-single-digits, non-GAAP EPS halves toward ~$1.2–1.5, and a 38x multiple on a no-growth cyclical collapses — plausible 40–55% downside to the $55–75 zone (roughly the late-2025 range).
• Single scenario that permanently impairs: not bankruptcy (net cash) — but a structural China-cost-competition + tariff bifurcation that permanently caps Diodes' share-gain runway and pins gross margin in the low-30s forever, turning it into a perpetual sub-scale cyclical that never earns the re-rate back. Plausibility: moderate over a 3–5 yr horizon.

Lens 14 · Management Questions (ordered by information value)

1. Gross margin has sat in the low-30s for two years against a 40% goal articulated for years — what specifically gets you from 31.8% to the 35%+ interim, and on what quarterly cadence should we hold you to?
2. ASPs fell 6.9% YoY in Q1 even as volume rose 31% — how much of the recovery is durable content/share gain vs. simply buying volume with price, and where does that leave normalized margin?
3. Walk us through the Atlas Magnetics structure: you hold a majority interest but don't consolidate, and a +$33.3M fair-value mark drove a chunk of FY2025 EPS — what is the basis for non-consolidation, and how should we think about future marks?
4. Inventory is ~169 days and building into the recovery — what is the right level, and what's the obsolescence exposure if book-to-bill turns?
5. You're guiding ~$435M for Q2 (+31% YoY) — what's your read on where we are in the semi cycle, and what would the early signs of a roll-over look like in your book-to-bill?
6. 77–78% of revenue and most manufacturing is in Asia — how are you de-risking China/Taiwan tariff and geopolitical exposure beyond the Maine and Scotland fabs?
7. How much of the current strength is Nexperia share-gain that could reverse, and what's the sticky vs. transient split?
8. Define your AI-server content dollar-per-unit today vs. two years ago, and the realistic 3-year trajectory — and is it accretive or dilutive to corporate gross margin?
9. Capital allocation: with ~$321M net cash and a 0% dividend, why buybacks over a dividend, and what's the M&A pipeline after Fortemedia/ATX?
10. The Keylink relationship (lease + ~$13.9M/yr plating/rental/consulting to a 5% JV partner) — is this arm's-length and is there a path to simplify it?
11. Automotive has been flat at 19% of revenue for three years despite being a stated priority — why hasn't the mix shifted, and what's the design-win backlog say about 2027–28?
12. What's the right through-cycle operating margin for this business, and how does the hybrid (internal + external) manufacturing mix move it?
13. R&D rose 21% in FY2025 to ~11% of sales — which product lines is that funding, and what's the expected revenue return and timing?
14. With foreign earnings indefinitely reinvested and ~$94M subject to withholding if repatriated, how much of the cash is truly accessible for U.S. buybacks/M&A?
15. What single external variable (tariffs, China demand, a specific competitor, FX) most threatens the 3-year $2.0B/$700M/>$4.00 plan, and what's your hedge?

---